Drug General Information (ID: DDIJ542ZYS)
  Drug Name Epirubicin Drug Info Candida albicans Drug Info
  Drug Type Small molecule Allergenics
  Therapeutic Class Antineoplastics Allergy Test
  Structure

 Mechanism of Epirubicin-Candida albicans Interaction (Severity Level: Moderate)
     Diminish the response to diagnostic skin test antigens Click to Show/Hide Mechanism Graph
      Drug Name Epirubicin Candida albicans
      Mechanism Immunosuppressive effects Diagnostic skin test antigens
      Key Mechanism Factor 1
Factor Name Diagnostic skin test antigens
Factor Description The efficacy of diagnostic skin test antigens may be reduced, leading to falsely insignificant or false-negative results may occur in such patients.
      Mechanism Description
  • Reduced reactions to diagnostic skin test antigens for Candida albicans when combined with Epirubicin 

Recommended Action
      Management Clinicians should be aware of the potential for falsely insignificant or false-negative results when administering diagnostic skin test antigens to patients treated with immunosuppressive agents.

References
1 Product Information. Tuberculin PPD (Mantoux) (tuberculin purified protein derivative). Connaught Laboratories Ltd, Toronto, ON.
2 Product Information. Candin (candida albicans extract). Nielsen Biosciences Inc, San Diego, CA.
3 Product Information. Spherulin (coccidioidin skin test). ALK Laboratories Inc, Wallingford, CT.